Amyotrophic lateral sclerosis: Insights from genetics

Archives of Neurology

Volumn 54, Issue 10, 1997, Pages 1246-1250

  Brown Jr , Robert H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; FASCICULATION; HUMAN; MOTONEURON; MUSCLE ATROPHY; PARALYSIS; PRIORITY JOURNAL; SPINAL CORD MOTONEURON;

EID: 14444268768     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1997.00550220050013     Document Type: Article

References (50)

1. Mulder D, Kurland L, Offord K, Beard C. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology. 1986;36:511-517.
2. Brownell S, Oppenheimer DR, Hughes JT. The central nervous system in motor neurone disease. J Neurol Neurosurg Psychiatry. 1970;33:338-357.
3. Leigh PN, Anderton BH, Dodson A, Gallo JM, Swash M, Power DM. Ubiquitin deposits in anterior horn cells in motor neurone disease. Neurosci Lett. 1988; 93:197-203.
4. Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system disease (chronic juvenile amyotrophic lateral sclerosis). Brain. 1990;113:347-363.
5. Hentati A, Bejaoui K, Pericak-Vance MA, et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-35. Nat Genet. 1994;7:425-428.
6. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59-62.
7. Figlewicz DA, Krizus A, Martinoli MG, et al. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet 1994;3:1757-1761.
8. Appel S, Smith R, Engelhardt J, Stefani E. Evidence of autoimmunity in amyotrophic lateral sclerosis. J Neurol Sci. 1994;124(suppl):14-19.
9. Rothstein JD, Martin LJ, Kuncl RW. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. N Engl J Med. 1992;236:1464-1468.
10. Rothstein J, Kammen M, Levey A, Martin L, Kuncl R. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann Neurol. 1995; 38:73-84.
11. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med. 1994;330:585-591.
12. Siddique TS, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med. 1991;324:1381-1384.
13. Fridovich I. Superoxide dismutases. Adv Enzymol. 1986;58:61-97.
14. Fridovich I. Biological effects of the superoxide radical. Arch Biochem Biophys. 1986;247:1-11.
15. Robberecht W, Sapp P, Vianne MK, et al. Cu/Zn superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem. 1993;62:384-387.
16. Deng H-X, Hantati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 1993;261:1047-1051.
17. Bowling A, Mutisya E, Walker L, Price D, Cork L, Beal M. Age-dependent impairment of mitochondrial function in primate brain. J Neurochem. 1993;60:1964-1967.
18. Bowling A, Barkowski E, McKenna-Yasek D, et al. Superoxide dismutase concentration and activity in familial amyotrophic lateral sclerosis. J Neurochem. 1995;64:2366-2369.
19. Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci U S A. 1994;91:8292-8296.
20. Borchelt DR, Guarnieri M, Wong P-C, et al. Superoxide dismutase 1 subunits with mutations linked to familial amyotrophic lateral sclerosis do not affect wild-type subunit function. J Biol Chem. 1995;270:1-5.
21. Gurney ME, Pu H, Chiu AY, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772-1775.
22. Ripps ME, Huntley GW, Hof PR, Morrison JH, Gordon JW. Transgenic mice expressing an altered murine superoxide dismutase gene provide an animal model of amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 1995;92:689-693.
23. Wong P, Pardo C, Borchelt D, et al. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 1995;14:1105-1116.
24. Reaume A, Elliot J, Hoffman E, et al. Motor neurons in Cu/Zn superoxide dismutase-deficient mice develop normally but exhibit enhanced cell death after axonal injury. Nat Genet. 1996;13:43-47.
25. Nishida C, Gralla E, Valentine J. Characterization of three yeast copper-zinc superoxide dismutase mutants analogous to those coded for in familial amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A. 1994;91:9906-9910.
26. Ischiropoulos H, Zhu L, Chen J, et al. Peroxynitrite-mediated tyrosine nitration catalyzed by superoxide dismutase. Arch Biochem Biophys. 1992;298:431-437.
27. Beckman JS, Carson M, Smith CD, Kuppenol WH. ALS, SOD, and peroxynitrite. Nature. 1993;364:584,
28. Hodgson E, Fridovich I. The interaction of bovine erythrocyte superoxide dismutase with hydrogen peroxide: inactivation of the enzyme. Biochemistry. 1975; 14:5294-5299.
29. Wiedau-Pazos M, Goto J, Rabizadeh S, et al. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 1996;271:515-518.
30. Yim M, Kang J, Yim H, Kwak H, Chock P, Stadtman E, A gain-of-function mutation of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: an enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc Natl Acad Sci U S A. 1996;93:5709-5714.
31. Lyons T, Liu H, Goto J, et al. Mutations in copper zinc superoxide dismutase that cause amyotrophic lateral sclerosis alter the zinc binding site and the redox behavior of the protein. Proc Natl Acad Sci U S A. 1996;93:12240-12244.
32. Rothstein JD, Bristol LA, Hosier BA, Brown RHJ, Kuncl RW. Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons. Proc Natl Acad Sci U S A. 1994;91:4155-4159.
33. Troy CM, Shelanski M. Down-regulation of copper/zinc superoxide dismutase causes apoptotic death in PC12 neuronal cells. Proc Natl Acad Sci U S A. 1994; 91;6384-6387.
34. Greenlund L, Deckwerth T, Johnson E. Superoxide dismutase delays neuronal apoptosis: a role for reactive oxygen species in programmed neuronal death. Neuron. 1995;14:303-315.
35. Rabizadeh S, Gralla E, Borchelt D, et al. Mutations associated with amyotrophic lateral sclerosis convert superoxide dismutase from an antiapoptotic gene to a proapoptotic gene: studies in yeast and neural cells. Proc Natl Acad Sci USA. 1995;92:3024-3028.
36. Figlewicz D, Roy J, Dong L, Durham H. Gain-of-function neurotoxic effects of mutant SOD-1 proteins in a primary culture model of amyotrophic lateral sclerosis. In: Program and abstracts of the International Symposium on ALS: November 11-13, 1996; Chicago, III. Abstract.
37. Roos R, Lee J, Bindokas VP, et al. Gene delivery by replication-deficient recombinant adenoviruses (AdVs) in the study of Cu,Zn superoxide dismutase type 1 (SOD-1)-linked familial amyotrophic lateral sclerosis (FALS) Neurology. 1997; 48:A150. Abstract.
38. Kunst C, Mezey E, Brownstein M, Patterson D. Mutations in SOD1 associated with familial ALS cause novel protein interactions. Nat Genet. 1997;15:91-94.
39. Koh J, Suh S, Gwag B, He Y, Hsu C, Choi D. The role of zinc in selective neuronal death after transient global cerebral ischemia. Science. 1996;272:1013-1016.
40. Chou S, Wang H, Taniguchi A. Role of SOD-1 and nitric oxide/cyclic GMP cascade in neurofilament aggregation in ALS/MND. J Neurol Sci. 1996;139:16-26.
41. Chou S, Wang H, Komai K. Colocalization of NOS and SOD1 in neurofilament accumulations within motor neurons of amyotrophic lateral sclerosis: an immunohistochemical study. J Chem Neuroanat. 1996;10:249-258.
42. Shaw P, Ince P, Falkous G, Mantle D. Oxidative damage to protein in sporadic motor neuorone disease spinal cord. Ann Neurol. 1995;38:691-695.
43. Gurney M, Cutting F, Zhai P, et al. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial ALS. Ann Neurol. 1996;39:147-158.
44. Choi DW. Glutamate toxicity and diseases of the nervous system. Neuron. 1988; 1:623-634.
45. Dykens JA. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated calcium and sodium: implications for neurodegeneration. J Neurochem. 1993;63:584-591.
46. Beal MF, Hyman BT, Koroshetz W. Do defects in mitochondrial energy metabolism underlie the pathology of neurodegenerative diseases? Trends Neurosci. 1993;16:125-131.
47. Beal M. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol. 1995;38:357-366.
48. Alexianu M, Ho B, Mohamed A, Bella VL, Smith R, Appel S. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol. 1994;36:846-858.
49. Alexianu M, Mohamed A, Smith R, Colom L, Appel S. Apoptotic cell death of a hybrid motoneuron cell line induced by immunoglobulins from patients with amyotrophic lateral sclerosis. J Neurochem. 1994;63:2365-2368.
50. Lee MK, Cleveland DW. A mutant neurofilament subunit causes massive, selective motor neuron death: implications for the pathogenesis of human motor neuron disease. Neuron. 1994;13:975-988.